Quarterly report pursuant to Section 13 or 15(d)

STOCK INCENTIVE PLANS AND SHARE-BASED COMPENSATION

v2.4.0.6
STOCK INCENTIVE PLANS AND SHARE-BASED COMPENSATION
9 Months Ended
Dec. 31, 2011
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE 9: STOCK INCENTIVE PLANS AND SHARE-BASED COMPENSATION

Overview

Our stock incentive plans (“Plans”) are broad-based, long-term retention programs that are intended to attract and retain talented employees and align stockholder and employee interests. The Plans provide for the issuance of stock options, stock appreciation rights, stock purchase rights and long-term performance awards to our employees, officers and affiliates. We also have an employee stock purchase plan (“Purchase Plan”) that allows for the purchase of stock at 85% of fair market value at the date of grant or the exercise date, whichever value is less.

During the first quarter of fiscal 2012, we assumed outstanding unvested options and unvested restricted shares of Pancetera which were exchanged into options and unvested restricted shares of Quantum common stock, respectively, in accordance with the merger agreement. As of June 13, 2011, Pancetera had approximately 0.8 million unvested stock options and 0.5 million unvested restricted shares outstanding. Based on the exchange ratio of 0.2403 calculated in accordance with the formula in the merger agreement, we assumed the outstanding unvested options, which are exercisable for an aggregate of 194,000 shares of Quantum common stock. Based on the relative cash and stock consideration for Pancetera shares per the merger agreement, the unvested restricted shares became 33,000 unvested restricted shares of Quantum common stock and $200,000 in cash held in escrow. The estimated fair value of unvested Pancetera options, unvested restricted shares and cash held in escrow related to future service is being recognized over the remaining service period.

The Black-Scholes option pricing model is used to estimate the fair value of options granted under our Plans, options assumed and rights to acquire stock granted under our Purchase Plan.

Share-Based Compensation

The following table summarizes share-based compensation (in thousands):

Three Months Ended Nine Months Ended
      December 31,
2011
      December 31,
2010
      December 31,
2011
      December 31,
2010
Share-based compensation:
       Cost of revenue $      495 $      459 $      1,518 $      1,363
       Research and development 795 603 2,466 1,933
       Sales and marketing   1,127     786     3,059   2,391
       General and administrative   1,007 686 3,203 2,363
$ 3,424 $ 2,534 $ 10,246 $ 8,050
 
Share-based compensation by type of award:
       Stock options $ 583 $ 772 $ 2,116 $ 2,807
       Restricted stock 2,377 1,287 6,586 3,988
       Stock purchase plan 464 475 1,544 1,255
$ 3,424 $ 2,534 $ 10,246 $ 8,050
 
Stock Options

No stock options were granted in the third quarter of fiscal 2012 and 2011. The weighted-average grant date fair values of employee stock option grants, as well as the weighted-average assumptions used in calculating these values for the first nine months of fiscal 2012 and 2011, were based on estimates at the date of grant as follows:

Nine Months Ended
      December 31,
2011
      December 31,
2010
Option life (in years) 4.0 4.2
Risk-free interest rate 1.57% 2.02%
Stock price volatility     112.33%     106.75%
Weighted-average grant date fair value $      1.91 $      1.96
 

The weighted-average fair value of stock options assumed from Pancetera, as well as the weighted-average assumptions used in calculating these values were based on estimates at the acquisition date as follows:

Option life (in years) 5.2
Risk-free interest rate 1.65%
Stock price volatility   100.93%
Weighted-average grant date fair value $      2.67
 

The assumed options have a 10 year contractual life from the original grant date.

Restricted Stock

The fair value of the restricted stock units granted is the intrinsic value as of the respective grant date since the restricted stock units are granted at no cost to the employees. The weighted-average grant date fair values of restricted stock units granted during the third quarter and first nine months of fiscal 2012 were $2.27 and $3.15, respectively. The weighted-average grant date fair values of restricted stock units granted during the third quarter and first nine months of fiscal 2011 were $2.73 and $1.95, respectively.

Stock Purchase Plan

Under the Purchase Plan, rights to purchase shares are typically granted during the second and fourth quarter of each fiscal year. The value of rights to purchase shares granted in the first nine months of fiscal 2012 and fiscal 2011, respectively, was estimated at the date of the grant. The weighted-average grant date fair values and the assumptions used in calculating fair values for the nine month periods ended December 31, 2011 and 2010 are as follows:

Nine Months Ended
      December 31,
2011
      December 31,
2010
Option life (in years) 0.5 0.5
Risk-free interest rate 0.08% 0.20%
Stock price volatility   56.27%     66.91%
Weighted-average grant date fair value $      0.54 $      0.48
 

Stock Activity

Stock Options

A summary of activity relating to our stock options follows (options and aggregate intrinsic value in thousands):

Options Weighted-
Average
Exercise Price
Weighted-
Average
Remaining
Contractual Term
Aggregate
Intrinsic Value
Outstanding as of March 31, 2011       22,080       $ 2.43            
       Granted and assumed 1,619 2.33
       Exercised (2,660 ) 1.87
       Forfeited (558 ) 1.88
       Expired   (488 )     9.01
Outstanding as of December 31, 2011 19,993   $      2.35 2.94 $      10,657
Vested and expected to vest at December 31, 2011 19,689 $ 2.35 2.90   $ 10,501
Exercisable as of December 31, 2011 16,483 $ 2.49   2.43 $ 7,804
 
Restricted Stock

A summary of activity relating to our restricted stock follows (shares in thousands):

Shares Weighted-Average
Grant Date
Fair Value
Nonvested at March 31, 2011       6,640       $ 1.95
       Granted and assumed 6,611   3.14
       Vested   (2,656 )   1.80
       Forfeited (936 ) 2.56
Nonvested at December 31, 2011 9,659 $ 2.75